The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis

Journal of Cell Science

Volumn 127, Issue 18, 2014, Pages 3877-3883

  Meyer, Hemmo ^a   Weihl, Conrad C ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ALS; Cdc48; IBMPFD; p97; Ubiquitin; VCP

Indexed keywords

PROTEIN P97; RNA; UBIQUITIN; VALOSIN CONTAINING PROTEIN; ADENOSINE TRIPHOSPHATASE; CDC48 PROTEIN; CELL CYCLE PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CELL CYCLE PROGRESSION; CELL FUNCTION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENOMIC INSTABILITY; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MISSENSE MUTATION; MOLECULAR BIOLOGY; NONHUMAN; PAGET BONE DISEASE; PARKINSON DISEASE; PATHOGENESIS; PHENOTYPE; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; STRESS; ANIMAL; DISEASES; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGICAL STRESS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL CYCLE PROTEINS; DISEASE; GENE EXPRESSION REGULATION; HUMANS; PATHOLOGY; STRESS, PHYSIOLOGICAL;

EID: 84907059487     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.093831     Document Type: Article

References (102)

1. Abramzon, Y., Johnson, J. O., Scholz, S. W., Taylor, J. P., Brunetti, M., Calvo, A., Mandrioli, J., Benatar, M., Mora, G., Restagno, G. et al. (2012). Valosincontaining protein (VCP) mutations in sporadic amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2231.
2. Acs, K., Luijsterburg, M. S., Ackermann, L., Salomons, F. A., Hoppe, T. and Dantuma, N. P. (2011). The AAA-ATPase VCP/p97 promotes 53BP1 recruitment by removing L3MBTL1 from DNA double-strand breaks. Nat. Struct. Mol. Biol. 18, 1345-1350.
3. Alexandru, G., Graumann, J., Smith, G. T., Kolawa, N. J., Fang, R. and Deshaies, R. J. (2008). UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134, 804-816.
4. Badadani, M., Nalbandian, A., Watts, G. D., Vesa, J., Kitazawa, M., Su, H., Tanaja, J., Dec, E., Wallace, D. C., Mukherjee, J. et al. (2010). VCP associated inclusion body myopathy and paget disease of bone knock-in mouse model exhibits tissue pathology typical of human disease. PLoS ONE 5, e13183.
5. Benatar, M., Wuu, J., Fernandez, C., Weihl, C. C., Katzen, H., Steele, J., Oskarsson, B. and Taylor, J. P. (2013). Motor neuron involvement in multisystem proteinopathy: implications for ALS. Neurology 80, 1874-1880.
6. Bengtson, M. H. and Joazeiro, C. A. (2010). Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature 467, 470-473.
7. Bergink, S., Ammon, T., Kern, M., Schermelleh, L., Leonhardt, H. and Jentsch, S. (2013). Role of Cdc48/p97 as a SUMO-targeted segregase curbing Rad51-Rad52 interaction. Nat. Cell Biol. 15, 526-532.
8. Beskow, A., Grimberg, K. B., Bott, L. C., Salomons, F. A., Dantuma, N. P. and Young, P. (2009). A conserved unfoldase activity for the p97 AAA-ATPase in proteasomal degradation. J. Mol. Biol. 394, 732-746.
9. Brandman, O., Stewart-Ornstein, J., Wong, D., Larson, A., Williams, C. C., Li, G. W., Zhou, S., King, D., Shen, P. S., Weibezahn, J. et al. (2012). A ribosomebound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell 151, 1042-1054.
10. Brunger, A. T. and DeLaBarre, B. (2003). NSF and p97/VCP: similar at first, different at last. FEBS Lett. 555, 126-133.
11. Buchan, J. R., Kolaitis, R. M., Taylor, J. P. and Parker, R. (2013). Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 153, 1461-1474.
12. Bug, M. and Meyer, H. (2012). Expanding into new markets-VCP/p97 in endocytosis and autophagy. J. Struct. Biol. 179, 78-82.
13. Cao, K., Nakajima, R., Meyer, H. H. and Zheng, Y. (2003). The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis. Cell 115, 355- 367.
14. Chan, N., Le, C., Shieh, P., Mozaffar, T., Khare, M., Bronstein, J. and Kimonis, V. (2012). Valosin-containing protein mutation and Parkinson's disease. Parkinsonism Relat. Disord. 18, 107-109.
15. Chu, J., Hong, N. A., Masuda, C. A., Jenkins, B. V., Nelms, K. A., Goodnow, C. C., Glynne, R. J., Wu, H., Masliah, E., Joazeiro, C. A. et al. (2009). A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc. Natl. Acad. Sci. USA 106, 2097-2103.
16. Davis, E. J., Lachaud, C., Appleton, P., Macartney, T. J., Na¨thke, I. and Rouse, J. (2012). DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage. Nat. Struct. Mol. Biol. 19, 1093-1100.
17. Defenouille`re, Q., Yao, Y., Mouaikel, J., Namane, A., Galopier, A., Decourty, L., Doyen, A., Malabat, C., Saveanu, C., Jacquier, A. et al. (2013). Cdc48-associated complex bound to 60S particles is required for the clearance of aberrant translation products. Proc. Natl. Acad. Sci. USA 110, 5046-5051.
18. DeHoratius, C. and Silver, P. A. (1996). Nuclear transport defects and nuclear envelope alterations are associated with mutation of the Saccharomyces cerevisiae NPL4 gene. Mol. Biol. Cell 7, 1835-1855.
19. Djamshidian, A., Schaefer, J., Haubenberger, D., Stogmann, E., Zimprich, F., Auff, E. and Zimprich, A. (2009). A novel mutation in the VCP gene (G157R) in a German family with inclusion-body myopathy with Paget disease of bone and frontotemporal dementia. Muscle Nerve 39, 389-391.
20. Dobrynin, G., Popp, O., Romer, T., Bremer, S., Schmitz, M. H., Gerlich, D. W. and Meyer, H. (2011). Cdc48/p97-Ufd1-Npl4 antagonizes Aurora B during chromosome segregation in HeLa cells. J. Cell Sci. 124, 1571-1580.
21. Dreveny, I., Pye, V. E., Beuron, F., Briggs, L. C., Isaacson, R. L., Matthews, S. J., McKeown, C., Yuan, X., Zhang, X. and Freemont, P. S. (2004). p97 and close encounters of every kind: a brief review. Biochem. Soc. Trans. 32, 715-720.
22. Erzberger, J. P. and Berger, J. M. (2006). Evolutionary relationships and structural mechanisms of AAA+ proteins. Annu. Rev. Biophys. Biomol. Struct. 35, 93-114.
23. Erzurumlu, Y., Kose, F. A., Gozen, O., Gozuacik, D., Toth, E. A. and Ballar, P. (2013). A unique IBMPFD-related P97/VCP mutation with differential binding pattern and subcellular localization. Int. J. Biochem. Cell Biol. 45, 773-782.
24. Fecto, F., Yan, J., Vemula, S. P., Liu, E., Yang, Y., Chen, W., Zheng, J. G., Shi, Y., Siddique, N., Arrat, H. et al. (2011). SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440-1446.
25. Ferna´ndez-Sa´iz, V. and Buchberger, A. (2010). Imbalances in p97 co-factor interactions in human proteinopathy. EMBO Rep. 11, 479-485.
26. Fu, X., Ng, C., Feng, D. and Liang, C. (2003). Cdc48p is required for the cell cycle commitment point at Start via degradation of the G1-CDK inhibitor Far1p. J. Cell Biol. 163, 21-26.
27. Fujii, K., Kitabatake, M., Sakata, T. and Ohno, M. (2012). 40S subunit dissociation and proteasome-dependent RNA degradation in nonfunctional 25S rRNA decay. EMBO J. 31, 2579-2589.
28. Gallagher, P. S., Clowes Candadai, S. V. and Gardner, R. G. (2014). The requirement for Cdc48/p97 in nuclear protein quality control degradation depends on the substrate and correlates with substrate insolubility. J. Cell Sci. 127, 1980-1991.
29. Griciuc, A., Aron, L., Roux, M. J., Klein, R., Giangrande, A. and Ueffing, M. (2010). Inactivation of VCP/ter94 suppresses retinal pathology caused by misfolded rhodopsin in Drosophila. PLoS Genet. 6, e1001075.
30. Guyant-Mare´chal, L., Laquerrie`re, A., Duyckaerts, C., Dumanchin, C., Bou, J., Dugny, F., Le Ber, I., Fre´bourg, T., Hannequin, D. and Campion, D. (2006). Valosin-containing protein gene mutations: clinical and neuropathologic features. Neurology 67, 644-651.
31. Hackman, P., Sarparanta, J., Lehtinen, S., Vihola, A., Evila¨, A., Jonson, P. H., Luque, H., Kere, J., Screen, M., Chinnery, P. F. et al. (2013). Welander distal myopathy is caused by a mutation in the RNA-binding protein TIA1. Ann. Neurol. 73, 500-509.
32. Halawani, D., LeBlanc, A. C., Rouiller, I., Michnick, S. W., Servant, M. J. and Latterich, M. (2009). Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation. Mol. Cell. Biol. 29, 4484-4494.
33. Hu¨bbers, C. U., Clemen, C. S., Kesper, K., Bo¨ ddrich, A., Hofmann, A., Ka¨ma¨ra¨ inen, O., Tolksdorf, K., Stumpf, M., Reichelt, J., Roth, U. et al. (2007). Pathological consequences of VCP mutations on human striated muscle. Brain 130, 381-393.
34. Janiesch, P. C., Kim, J., Mouysset, J., Barikbin, R., Lochmu¨ ller, H., Cassata, G., Krause, S. and Hoppe, T. (2007). The ubiquitin-selective chaperone CDC- 48/p97 links myosin assembly to human myopathy. Nat. Cell Biol. 9, 379-390.
35. Jentsch, S. and Rumpf, S. (2007). Cdc48 (p97): a ''molecular gearbox'' in the ubiquitin pathway? Trends Biochem. Sci. 32, 6-11.
36. Ju, J. S. and Weihl, C. C. (2010). p97/VCP at the intersection of the autophagy and the ubiquitin proteasome system. Autophagy 6, 283-285.
37. Ju, J. S., Miller, S. E., Hanson, P. I. and Weihl, C. C. (2008). Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCPassociated disease. J. Biol. Chem. 283, 30289-30299.
38. Ju, J. S., Fuentealba, R. A., Miller, S. E., Jackson, E., Piwnica-Worms, D., Baloh, R. H. and Weihl, C. C. (2009). Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J. Cell Biol. 187, 875-888.
39. Kim, H. J., Kim, N. C., Wang, Y. D., Scarborough, E. A., Moore, J., Diaz, Z., MacLea, K. S., Freibaum, B., Li, S., Molliex, A. et al. (2013a). Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 495, 467-473.
40. Kim, N. C., Tresse, E., Kolaitis, R. M., Molliex, A., Thomas, R. E., Alami, N. H., Wang, B., Joshi, A., Smith, R. B., Ritson, G. P. et al. (2013b). VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 78, 65-80.
41. Kimonis, V. E., Fulchiero, E., Vesa, J. and Watts, G. (2008). VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder. Biochim. Biophys. Acta 1782, 744-748.
42. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y. and Shimizu, N. (1998). Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605- 608.
43. Kottlors, M., Moske-Eick, O., Huebner, A., Krause, S., Mueller, K., Kress, W., Schwarzwald, R., Bornemann, A., Haug, V., Heitzer, M. et al. (2010). Lateonset autosomal dominant limb girdle muscular dystrophy and Paget's disease of bone unlinked to the VCP gene locus. J. Neurol. Sci. 291, 79-85.
44. Kovach, M. J., Waggoner, B., Leal, S. M., Gelber, D., Khardori, R., Levenstien, M. A., Shanks, C. A., Gregg, G., Al-Lozi, M. T., Miller, T. et al. (2001). Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol. Genet. Metab. 74, 458-475.
45. Kress, E., Schwager, F., Holtackers, R., Seiler, J., Prodon, F., Zanin, E., Eiteneuer, A., Toya, M., Sugimoto, A., Meyer, H. et al. (2013). The UBXN-2/ p37/p47 adaptors of CDC-48/p97 regulate mitosis by limiting the centrosomal recruitment of Aurora A. J. Cell Biol. 201, 559-575.
46. Krick, R., Bremer, S., Welter, E., Schlotterhose, P., Muehe, Y., Eskelinen, E. L. and Thumm, M. (2010). Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J. Cell Biol. 190, 965-973.
47. Kruse, K. B., Brodsky, J. L. and McCracken, A. A. (2006). Characterization of an ERAD gene as VPS30/ATG6 reveals two alternative and functionally distinct protein quality control pathways: one for soluble Z variant of human alpha-1 proteinase inhibitor (A1PiZ) and another for aggregates of A1PiZ. Mol. Biol. Cell 17, 203-212.
48. Kulathu, Y. and Komander, D. (2012). Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages. Nat. Rev. Mol. Cell Biol. 13, 508-523.
49. Kwiatkowski, T. J., Jr, Bosco, D. A., Leclerc, A. L., Tamrazian, E., Vanderburg, C. R., Russ, C., Davis, A., Gilchrist, J., Kasarskis, E. J., Munsat, T. et al. (2009). Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 323, 1205-1208.
50. Laurin, N., Brown, J. P., Morissette, J. and Raymond, V. (2002). Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am. J. Hum. Genet. 70, 1582-1588.
51. Li, J. M., Wu, H., Zhang, W., Blackburn, M. R. and Jin, J. (2014). The p97- UFD1L-NPL4 protein complex mediates cytokine-induced IkBa proteolysis. Mol. Cell. Biol. 34, 335-347.
52. Lykke-Andersen, J. and Bennett, E. J. (2014). Protecting the proteome: Eukaryotic cotranslational quality control pathways. J. Cell Biol. 204, 467-476.
53. Majounie, E., Traynor, B. J., Chio, A., Restagno, G., Mandrioli, J., Benatar, M., Taylor, J. P. and Singleton, A. B. (2012). Mutational analysis of the VCP gene in Parkinson's disease. Neurobiol. Aging 33, 209 e201-e202.
54. Meerang, M., Ritz, D., Paliwal, S., Garajova, Z., Bosshard, M., Mailand, N., Janscak, P., Hu¨ bscher, U., Meyer, H. and Ramadan, K. (2011). The ubiquitinselective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat. Cell Biol. 13, 1376-1382.
55. Metzger, M. B., Hristova, V. A. and Weissman, A. M. (2012). HECT and RING finger families of E3 ubiquitin ligases at a glance. J. Cell Sci. 125, 531-537.
56. Meyer, H. H. (2005). Golgi reassembly after mitosis: the AAA family meets the ubiquitin family. Biochim. Biophys. Acta 1744, 108-119.
57. Meyer, H. (2012). p97 complexes as signal integration hubs. BMC Biol. 10, 48.
58. Meyer, H. J. and Rape, M. (2014). Enhanced protein degradation by branched ubiquitin chains. Cell 157, 910-921.
59. Meyer, H., Bug, M. and Bremer, S. (2012). Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat. Cell Biol. 14, 117-123.
60. Minetti, C., Sotgia, F., Bruno, C., Scartezzini, P., Broda, P., Bado, M., Masetti, E., Mazzocco, M., Egeo, A., Donati, M. A. et al. (1998). Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat. Genet. 18, 365-368.
61. Mosbech, A., Gibbs-Seymour, I., Kagias, K., Thorslund, T., Beli, P., Povlsen, L., Nielsen, S. V., Smedegaard, S., Sedgwick, G., Lukas, C. et al. (2012). DVC1 (C1orf124) is a DNA damage-targeting p97 adaptor that promotes ubiquitin-dependent responses to replication blocks. Nat. Struct. Mol. Biol. 19, 1084-1092.
62. Mu¨ ller, J. M., Deinhardt, K., Rosewell, I., Warren, G. and Shima, D. T. (2007). Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality. Biochem. Biophys. Res. Commun. 354, 459-465.
63. Ndoja, A., Cohen, R. E. and Yao, T. (2014). Ubiquitin signals proteolysisindependent stripping of transcription factors. Mol. Cell 53, 893-903.
64. Neumann, M., Mackenzie, I. R., Cairns, N. J., Boyer, P. J., Markesbery, W. R., Smith, C. D., Taylor, J. P., Kretzschmar, H. A., Kimonis, V. E. and Forman, M. S. (2007). TDP-43 in the ubiquitin pathology of frontotemporal dementia with VCP gene mutations. J. Neuropathol. Exp. Neurol. 66, 152-157.
65. Niwa, H., Ewens, C. A., Tsang, C., Yeung, H. O., Zhang, X. and Freemont, P. S. (2012). The role of the N-domain in the ATPase activity of the mammalian AAA ATPase p97/VCP. J. Biol. Chem. 287, 8561-8570.
66. Olzmann, J. A., Richter, C. M. and Kopito, R. R. (2013). Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover. Proc. Natl. Acad. Sci. USA 110, 1345-1350.
67. Ossareh-Nazari, B., Bonizec, M., Cohen, M., Dokudovskaya, S., Delalande, F., Schaeffer, C., Van Dorsselaer, A. and Dargemont, C. (2010). Cdc48 and Ufd3, new partners of the ubiquitin protease Ubp3, are required for ribophagy. EMBO Rep. 11, 548-554.
68. Parkinson, N., Ince, P. G., Smith, M. O., Highley, R., Skibinski, G., Andersen, P. M., Morrison, K. E., Pall, H. S., Hardiman, O., Collinge, J. et al.; MRC Proteomics in ALS Study; FReJA Consortium (2006). ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology 67, 1074-1077.
69. Puumalainen, M. R., Lessel, D., Ru¨ themann, P., Kaczmarek, N., Bachmann, K., Ramadan, K. and Naegeli, H. (2014). Chromatin retention of DNA damage sensors DDB2 and XPC through loss of p97 segregase causes genotoxicity. Nat. Commun. 5, 3695.
70. Radhakrishnan, S. K., den Besten, W. and Deshaies, R. J. (2014). p97- dependent retrotranslocation and proteolytic processing govern formation of active Nrf1 upon proteasome inhibition. eLife 3, e01856.
71. Ramadan, K., Bruderer, R., Spiga, F. M., Popp, O., Baur, T., Gotta, M. and Meyer, H. H. (2007). Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 450, 1258-1262.
72. Raman, M., Havens, C. G., Walter, J. C. and Harper, J. W. (2011). A genomewide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol. Cell 44, 72-84.
73. Riemer, A., Dobrynin, G., Dressler, A., Bremer, S., Soni, A., Iliakis, G. and Meyer, H. (2014). The p97-Ufd1-Npl4 ATPase complex ensures robustness of the G2/M checkpoint by facilitating CDC25A degradation. Cell Cycle 13, 919- 927.
74. Ritz, D., Vuk, M., Kirchner, P., Bug, M., Schu¨ tz, S., Hayer, A., Bremer, S., Lusk, C., Baloh, R. H., Lee, H. et al. (2011). Endolysosomal sorting of ubiquitylated caveolin-1 is regulated by VCP and UBXD1 and impaired by VCP disease mutations. Nat. Cell Biol. 13, 1116-1123.
75. Rohrer, J. D.,Warren, J. D., Reiman, D., Uphill, J., Beck, J., Collinge, J., Rossor, M. N., Isaacs, A. M. and Mead, S. (2011). A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromes. J. Neurol. 258, 1494-1496.
76. Rubino, E., Rainero, I., Chio`, A., Rogaeva, E., Galimberti, D., Fenoglio, P., Grinberg, Y., Isaia, G., Calvo, A., Gentile, S. et al.; TODEM Study Group (2012). SQSTM1 mutations in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Neurology 79, 1556-1562.
77. Schuberth, C. and Buchberger, A. (2008). UBX domain proteins: major regulators of the AAA ATPase Cdc48/p97. Cell. Mol. Life Sci. 65, 2360-2371.
78. Shi, Z., Hayashi, Y. K., Mitsuhashi, S., Goto, K., Kaneda, D., Choi, Y. C., Toyoda, C., Hieda, S., Kamiyama, T., Sato, H. et al. (2012). Characterization of the Asian myopathy patients with VCP mutations. Euro. J. Neurol. 19, 501-509.
79. Skibinski, G., Parkinson, N. J., Brown, J. M., Chakrabarti, L., Lloyd, S. L., Hummerich, H., Nielsen, J. E., Hodges, J. R., Spillantini, M. G., Thusgaard, T. et al. (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 37, 806-808.
80. Sowa, M. E., Bennett, E. J., Gygi, S. P. and Harper, J. W. (2009). Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403.
81. Spina, S., Van Laar, A. D., Murrell, J. R., Hamilton, R. L., Kofler, J. K., Epperson, F., Farlow, M. R., Lopez, O. L., Quinlan, J., DeKosky, S. T. et al. (2013). Phenotypic variability in three families with valosin-containing protein mutation. Euro. J. Neurol. 20, 251-258.
82. Sreedharan, J., Blair, I. P., Tripathi, V. B., Hu, X., Vance, C., Rogelj, B., Ackerley, S., Durnall, J. C., Williams, K. L., Buratti, E. et al. (2008). TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668-1672.
83. Stolz, A., Hilt, W., Buchberger, A. and Wolf, D. H. (2011). Cdc48: a power machine in protein degradation. Trends Biochem. Sci. 36, 515-523.
84. Tanaka, A., Cleland, M. M., Xu, S., Narendra, D. P., Suen, D. F., Karbowski, M. and Youle, R. J. (2010). Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J. Cell Biol. 191, 1367-1380.
85. Tresse, E., Salomons, F. A., Vesa, J., Bott, L. C., Kimonis, V., Yao, T. P., Dantuma, N. P. and Taylor, J. P. (2010). VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6, 217-227.
86. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G. et al. (2004). Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160.
87. Vaz, B., Halder, S. and Ramadan, K. (2013). Role of p97/VCP (Cdc48) in genome stability. Front. Genet. 4, 60.
88. Verma, R., Oania, R., Fang, R., Smith, G. T. and Deshaies, R. J. (2011). Cdc48/p97 mediates UV-dependent turnover of RNA Pol II. Mol. Cell 41, 82-92.
89. Verma, R., Oania, R. S., Kolawa, N. J. and Deshaies, R. J. (2013). Cdc48/p97 promotes degradation of aberrant nascent polypeptides bound to the ribosome. eLife 2, e00308.
90. Vieira, N. M., Naslavsky, M. S., Licinio, L., Kok, F., Schlesinger, D., Vainzof, M., Sanchez, N., Kitajima, J. P., Gal, L., Cavacana, N. et al. (2014). A defect in the RNA-processing protein HNRPDL causes limb-girdle muscular dystrophy 1G (LGMD1G). Hum. Mol. Genet. 23, 4103-4110.
91. Waggoner, B., Kovach, M. J., Winkelman, M., Cai, D., Khardori, R., Gelber, D. and Kimonis, V. E. (2002). Heterogeneity in familial dominant Paget disease of bone and muscular dystrophy. Am. J. Med. Genet. 108, 187-191.
92. Watts, G. D., Wymer, J., Kovach, M. J., Mehta, S. G., Mumm, S., Darvish, D., Pestronk, A., Whyte, M. P. and Kimonis, V. E. (2004). Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 36, 377-381.
93. Weihl, C. C., Dalal, S., Pestronk, A. and Hanson, P. I. (2006). Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulumassociated degradation. Hum. Mol. Genet. 15, 189-199.
94. Weihl, C. C., Miller, S. E., Hanson, P. I. and Pestronk, A. (2007). Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice. Hum. Mol. Genet. 16, 919-928.
95. Weihl, C. C., Temiz, P., Miller, S. E., Watts, G., Smith, C., Forman, M., Hanson, P. I., Kimonis, V. and Pestronk, A. (2008). TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 79, 1186-1189.
96. Weihl, C. C., Pestronk, A. and Kimonis, V. E. (2009). Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and frontotemporal dementia. Neuromuscul. Disord. 19, 308-315.
97. Weissman, A. M. (2001). Themes and variations on ubiquitylation. Nat. Rev. Mol. Cell Biol. 2, 169-178.
98. Yamanaka, K., Sasagawa, Y. and Ogura, T. (2012). Recent advances in p97/VCP/Cdc48 cellular functions. Biochim. Biophys. Acta 1823, 130-137.
99. Ye, Y. (2006). Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase. J. Struct. Biol. 156, 29-40.
100. Yeung, H. O., Kloppsteck, P., Niwa, H., Isaacson, R. L., Matthews, S., Zhang, X. and Freemont, P. S. (2008). Insights into adaptor binding to the AAA protein p97. Biochem. Soc. Trans. 36, 62-67.
101. c Lundberg, E., Uhlen, M. and Mann, M. (2012). A Protein Epitope Signature Tag (PrEST) library allows SILAC-based absolute quantification and multiplexed determination of protein copy numbers in cell lines. Mol. Cell Proteomics 11, O111 009613.
102. Zhou, H. L., Geng, C., Luo, G. and Lou, H. (2013). The p97-UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP. Genes Dev. 27, 1046-1058.